3 studies found for:    21639808 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Neoadjuvant Vemurafenib for BRAF Mutant Melanoma and Palpable Lymph Node Metastasis
Condition: Melanoma
Intervention: Drug: Vemurafenib
2 Recruiting Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: Neoplasms
Intervention: Genetic: Blood and tumor samples
3 Active, not recruiting
Has Results
A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
Condition: Malignant Melanoma
Interventions: Drug: RO5185426;   Drug: dacarbazine

Indicates status has not been verified in more than two years